HORMONE RECEPTOR AND HER-2 NEU STATUS IN BREAST CANCER PATIENTS ATTENDING RADIOTHERAPY OPD: AN INSTITUTIONAL EXPERIENCE

Journal Title: World Journal of Advance Healthcare Research - Year 2018, Vol 2, Issue 5

Abstract

Introduction: In breast cancer, hormonal status plays a very pivotal role in its etiology, prognosis and treatment in adjuvant as well as metastatic setting. This study explored hormonal profiles of the patients and metastasis in breast cancer. Materials & Methods: Breast cancer patient data were analysed retrospectively from institutional records during the study period from 1st January 2013 to 31st December 2017. The collected data was compiled into EpiInfo 7 software and subsequently analysis of data was done using SPSS software, version 16 and results are mentioned with the help of tables. Result and Discussion: Most of the breast cancer patients were of the age 40-60 years. Most of the patients had locally advanced carcinoma, 49.2%. Hormonal status was known for 82.2% of the patients. In our study ER positive, PR positive & Her-2 positive were 38.4%, 41.09% & 36.9% respectively of the whole sample and 46.67%, 50% & 45% respectively among the hormonal status known patients. Those who received hormonal therapy, were 31.5% amongst all the available records. Patients with HER2, ER & PR status positive (21.67%) and HER2 negative, but positive for ER & PR (16.67%) received hormonal therapy. While 23.33% patients did not receive hormonal therapy, being negative for HER2, ER & PR; it was also observed that 21.67% patients were not given any hormonal therapy, being ER & PR negative but HER2 positive. Conclusion: ER/PR positive was the most frequently observed hormonal profile in our population and this population is eligible for hormonal therapy.

Authors and Affiliations

Dr. Swapan Kumar Mallick

Keywords

Related Articles

A CLINICAL STUDY OF PERIMENOPAUSAL UTERINE BLEEDING

Aims: To determine the role of transvaginal ultrasonography in perimenopausal women with abnormal uterine bleeding and its correlation with histopathology. Materials and Methods: All cases of abnormal uterine bleeding in...

REVIEW ON ESTRUS SYNCHRONIZATION AND ITS APPLICATION IN CATTLE

Numbers of estrus synchronization programmes are available in cattle based on the use of various hormones like progesterone, prostaglandin F2α and their various combinations with other hormones like estrogen and Gonadotr...

IN SILICO STUDIES ON DENGUE AND SARS CORONA VIRAL PROTEINS WITH SELECTED CORIANDRUM SATIVUM LEAVES CONSTITUENTS

Dengue virus contains seven proteins and SARS Corona virus contains twelve proteins. Recent studies have shown that these proteins are considered to be the most effective for drug designing in humans. Phytochemicals pres...

EVALUATION OF PRESCRIPTION PATTERN AND QUALITY OF LIFE IN ACNE IN TERTIARY CARE HOSPITAL IN NORTH INDIAN POPULATION

The aim of this study was to evaluate the prescription pattern and Quality of Life of patients and severity of the disease by using Cardiff Acne Disability Index and Global Acne Grading System score respectively. A cross...

IN SILICO STUDIES ON DENGUE AND NIPAH VIRAL PROTEINS WITH SELECTED AZADIRACHTA INDICA LEAVES CONSTITUENTS

Dengue vrirus contains seven proteins and Nipah virus contains five proteins, which are considered to be most potent for drug designing. Recent studies have shown that these proteins can effectively cause the deactivatio...

Download PDF file
  • EP ID EP666019
  • DOI -
  • Views 158
  • Downloads 0

How To Cite

Dr. Swapan Kumar Mallick (2018). HORMONE RECEPTOR AND HER-2 NEU STATUS IN BREAST CANCER PATIENTS ATTENDING RADIOTHERAPY OPD: AN INSTITUTIONAL EXPERIENCE. World Journal of Advance Healthcare Research, 2(5), 123-125. https://europub.co.uk/articles/-A-666019